Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Arvinas Inc (NASDAQ: ARVN) was $7.58 for the day, up 1.34% from the previous closing price of $7.48. In other words, the price has increased by $1.34 from its previous closing price. On the day, 2.85 million shares were traded. ARVN stock price reached its highest trading level at $8.15 during the session, while it also had its lowest trading level at $7.57.
Ratios:
Our analysis of ARVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.58 and its Current Ratio is at 4.58. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 05, 2025, Truist Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 24 ’25 when Saik Andrew sold 5,700 shares for $7.61 per share. The transaction valued at 43,377 led to the insider holds 164,401 shares of the business.
Andrew Saik bought 5,927 shares of ARVN for $43,593 on Jun 24 ’25. On Jun 17 ’25, another insider, Cacace Angela M, who serves as the Chief Scientific Officer of the company, sold 2,583 shares for $7.49 each. As a result, the insider received 19,347 and left with 154,248 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARVN now has a Market Capitalization of 553274816 and an Enterprise Value of -390525248. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.44 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at -0.915 whereas that against EBITDA is 4.273.
Stock Price History:
The Beta on a monthly basis for ARVN is 2.23, which has changed by -0.7169529 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, ARVN has reached a high of $29.96, while it has fallen to a 52-week low of $5.90. The 50-Day Moving Average of the stock is 1.60%, while the 200-Day Moving Average is calculated to be -48.42%.
Shares Statistics:
ARVN traded an average of 2.41M shares per day over the past three months and 2022450 shares per day over the past ten days. A total of 73.00M shares are outstanding, with a floating share count of 63.64M. Insiders hold about 12.81% of the company’s shares, while institutions hold 89.06% stake in the company. Shares short for ARVN as of 1752537600 were 7818081 with a Short Ratio of 3.25, compared to 1749772800 on 8325671. Therefore, it implies a Short% of Shares Outstanding of 7818081 and a Short% of Float of 10.879999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
As of right now, 17.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.84, with high estimates of -$0.4 and low estimates of -$1.48.
Analysts are recommending an EPS of between $0.83 and -$4.22 for the fiscal current year, implying an average EPS of -$1.31. EPS for the following year is -$3.44, with 16.0 analysts recommending between -$1.45 and -$5.76.
Revenue Estimates
A total of 19 analysts have provided revenue estimates for ARVN’s current fiscal year. The highest revenue estimate was $439.8M, while the lowest revenue estimate was $131.7M, resulting in an average revenue estimate of $294.25M. In the same quarter a year ago, actual revenue was $263.4MBased on 19 analysts’ estimates, the company’s revenue will be $157.29M in the next fiscal year. The high estimate is $417.93M and the low estimate is $16.6M.
